
Therapeutics
Therapeutics, encompassing a range of treatments from neutralizing antibodies to therapeutics, stand as indispensable tools in the battle against infectious diseases like COVID-19 and influenza. These interventions not only save the lives of vulnerable populations but also provide critical support for severe cases, including those complicated by bacterial co-infections. Despite the challenges posed by viral mutations and antibiotic resistance, ongoing advancements in technology and drug discovery offer hope for more effective and resilient treatments. Breakthroughs in broadly neutralizing antibodies and innovative compounds like SA-558 show promise in enhancing treatment outcomes while minimizing the risk of resistance. As research progresses and novel therapeutics undergo rigorous testing, the future of combating infectious diseases looks increasingly promising.
Our Projects
Engineer bnAbs and bi-bnAbs against HIV or Respiratory Viruses
Host and Virus Targeting Broad-spectrum Antiviral Compounds
Host Cell Death Modulators as an Effective Antiviral Strategy against Emerging Viruses
Targeting Host and Viral Determinants in Cell Entry Machineries as a Novel Antiviral Strategy against Emerging Viruses
Effective Antibiotic-adjuvants for Co-infections and Secondary Infections with Viral Respiratory Diseases
-
